Lipid Peroxidation Assessment in Preclinical Alzheimer Disease Diagnosis

Lipid Peroxidation Assessment in Preclinical Alzheimer Disease Diagnosis

Alzheimer disease (AD) is an increasingly common neurodegenerative disease, especially in countries with aging populations. Its diagnosis is complex and is usually carried out in advanced stages of the disease. In addition, lipids and oxidative stress have been related to AD since the earliest stage...

Full description

Bibliographic Details
Main Authors: Carmen Peña-Bautista, Lourdes Álvarez-Sánchez, Inés Ferrer, Marina López-Nogueroles, Antonio José Cañada-Martínez, Camille Oger, Jean-Marie Galano, Thierry Durand, Miguel Baquero, Consuelo Cháfer-Pericás
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Antioxidants
Subjects:
Alzheimer disease
plasma
biomarker
lipid peroxidation
mass spectrometry
preclinical
Online Access:https://www.mdpi.com/2076-3921/10/7/1043

Internet

https://www.mdpi.com/2076-3921/10/7/1043

Similar Items